AVTX vs CLOV
Avalo Therapeutics Inc (AVTX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AVTX and CLOV stock pages for the full models.
Not investment advice.